NeurAxis, Inc. (NRXS)
NYSEAMERICAN: NRXS · Real-Time Price · USD
7.27
+0.36 (5.21%)
At close: Jun 26, 2026, 4:00 PM EDT
7.27
0.00 (0.00%)
After-hours: Jun 26, 2026, 4:10 PM EDT
NeurAxis Market Cap
NeurAxis has a market cap or net worth of $90.03 million as of June 26, 2026. Its market cap has increased by 279.54% in one year.
Market Cap
90.03M
Enterprise Value
83.31M
1-Year Change
279.54%
Ranking
Category
Stock Price
$7.27
Market Cap Chart
Since the IPO on August 9, 2023, NeurAxis's market cap has increased from $18.37M to $90.03M, an increase of 390.07%. That is a compound annual growth rate of 73.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 90.03M | 86.16% |
| Dec 31, 2025 | 48.36M | 194.84% |
| Dec 31, 2024 | 16.40M | 16.15% |
| Dec 29, 2023 | 14.12M | -23.13% |
| Aug 9, 2023 | 18.37M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rein Therapeutics | 90.12M |
| ImmuCell | 89.25M |
| Biomea Fusion | 88.93M |
| Champions Oncology | 86.51M |
| Telomir Pharmaceuticals | 85.97M |
| Adicet Bio | 85.58M |
| Cardiff Oncology | 85.46M |
| Alterity Therapeutics | 84.37M |